[{"NetIncomeLoss_1_Q2_USD":-17974000.0,"Liabilities_0_Q2_USD":123365000.0,"HeldToMaturitySecurities_0_Q2_USD":67184000.0,"MarketableSecuritiesCurrent_0_Q2_USD":45278000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":16925000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8043000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":28990000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":29034000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-16000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":15931000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":680000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1278000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1062317.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":445754000.0,"CurrentFederalTaxExpenseBenefit_2_Q2_USD":38000.0,"AssetsCurrent_0_Q2_USD":211404000.0,"DueToRelatedPartiesNoncurrent_0_Q2_USD":81474000.0,"CurrentStateAndLocalTaxExpenseBenefit_2_Q2_USD":12000.0,"CurrentStateAndLocalTaxExpenseBenefit_1_Q2_USD":36000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":17844000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_2_Q2_USD":-3000.0,"IncomeTaxesPaidNet_2_Q2_USD":25000.0,"CommonStockSharesIssued_0_Q2_shares":29047344.0,"Assets_0_Q2_USD":223661000.0,"DebtAndEquitySecuritiesUnrealizedGainLoss_2_Q2_USD":79000.0,"ShareBasedCompensation_2_Q2_USD":3483000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4531000.0,"CurrentFederalTaxExpenseBenefit_1_Q2_USD":94000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3119000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":152088000.0,"OtherAssetsNoncurrent_0_Q2_USD":1168000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-9255000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":30696000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":13709000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-1107000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2556000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":918000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2247000.0,"AccountsReceivableNetCurrent_0_Q2_USD":142000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.856,"IncomeTaxExpenseBenefit_1_Q2_USD":31000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":128000.0,"CommonStockValue_0_Q2_USD":2935000.0,"Revenues_2_Q2_USD":12357000.0,"Revenues_1_Q2_USD":6056000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":532000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":539000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-2346000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":729000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_2_Q2_USD":16000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_1_Q2_USD":-36000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":28181000.0,"DeferredRevenueNoncurrent_0_Q2_USD":457000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":197400000.0,"OtherAssetsCurrent_0_Q2_USD":3643000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-599000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":134000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.015,"DeferredIncomeTaxAssetsNet_0_Q2_USD":210000.0,"CommonStockParOrStatedValuePerShare_0_Q2_EUR":0.09,"InterestReceivableCurrent_0_Q2_USD":155000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":11.91,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-45524000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-681000.0,"CommonStockSharesOutstanding_0_Q2_shares":29047344.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":28947000.0,"DeferredFederalIncomeTaxExpenseBenefit_2_Q2_USD":62000.0,"DeferredFederalIncomeTaxExpenseBenefit_1_Q2_USD":-63000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-34346000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-17943000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1192000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-906000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":2201000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-43868000.0,"LiabilitiesCurrent_0_Q2_USD":38315000.0,"DeferredRevenueCurrent_0_Q2_USD":727000.0,"AccountsPayableCurrent_0_Q2_USD":2362000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":152289000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":12087000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":893000.0,"SeveranceCosts1_2_Q2_USD":100000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":13000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":789000.0,"OperatingLeasePayments_1_Q2_USD":396000.0,"HeldToMaturitySecuritiesFairValue_0_Q2_USD":67355000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":35000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3617000.0,"NetIncomeLoss_2_Q2_USD":-34474000.0,"LeaseCost_1_Q2_USD":503000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-15773000.0,"LeaseCost_2_Q2_USD":981000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":50000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":6441000.0,"CommonStockSharesAuthorized_0_Q2_shares":45000000.0,"OperatingIncomeLoss_2_Q2_USD":-35264000.0,"OperatingIncomeLoss_1_Q2_USD":-15696000.0,"InvestmentIncomeInterest_2_Q2_USD":379000.0,"InvestmentIncomeInterest_1_Q2_USD":99000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":78000.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":-99000.0,"OperatingLeaseCost_2_Q2_USD":792000.0,"OperatingLeaseCost_1_Q2_USD":396000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":223661000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2206000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3483000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1192000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1451000.0,"OperatingExpenses_2_Q2_USD":47621000.0,"OperatingExpenses_1_Q2_USD":21752000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.22,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.54,"ProfitLoss_2_Q2_USD":-34474000.0,"StockholdersEquity_0_Q2_USD":100296000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":512000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":2731000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":1809000.0,"VariableLeaseCost_2_Q2_USD":189000.0,"VariableLeaseCost_1_Q2_USD":107000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-349073000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":130000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-35380000.0,"Ticker":"MRUS","CIK":"1651311","name":"MERUS N.V.","OfficialName":"Merus N.V. Common Shares","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1055622823.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]